Agent: Pharmacia Corporation Global Patent Department20090286876 - Neuroprotective benzoate and benzamide compounds: The invention provides a therapeutic method for treating at least one symptom of a neurological disorder or disease such as Alzheimer's disease in a mammal, such as a human, wherein the toxicity of a pathogen of ?? amyloid peptide and/or glutamate in mammalian cells is implicated an